Drug:
Reaction: NO ADVERSE EVENT
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26547977 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 302 | 26547978 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 303 | 26547979 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 304 | 26547981 |
US |
2 | |
Product adhesion issue, Product substitution issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 305 | 26547984 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 306 | 26547985 |
US |
2 | |
Wrong technique in device usage process, Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 307 | 26548018 |
US |
||
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 308 | 26548019 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 309 | 26548022 |
US |
67 | 2 |
Product packaging issue, Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 310 | 26548023 |
US |
||
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 311 | 26548024 |
US |
||
Product packaging issue, Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 312 | 26548025 |
US |
2 | |
Product quality issue, Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 313 | 26548026 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 314 | 26548028 |
US |
||
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 315 | 26548029 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 316 | 26548030 |
US |
2 | |
Product adhesion issue, Product packaging issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 317 | 26548074 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 318 | 26548075 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 319 | 26548076 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 320 | 26548078 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 321 | 26548079 |
US |
2 | |
Product adhesion issue, Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, ESTRADIOL, |
||||
| 322 | 26548081 |
US |
||
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 323 | 26548083 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 324 | 26548084 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 325 | 26548110 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 326 | 26548111 |
US |
||
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 327 | 26548112 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 328 | 26548116 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 329 | 26548117 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 330 | 26548118 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 331 | 26548154 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 332 | 26548155 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 333 | 26548156 |
US |
2 | |
Product physical issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 334 | 26548160 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 335 | 26548161 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 336 | 26548162 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, ESTRADIOL, |
||||
| 337 | 26548163 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 338 | 26548204 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 339 | 26548206 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 340 | 26548208 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 341 | 26548209 |
US |
2 | |
Product packaging quantity issue, Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 342 | 26548210 |
US |
2 | |
Product quality issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 343 | 26548211 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 344 | 26548213 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 345 | 26548251 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 346 | 26548253 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 347 | 26548254 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 348 | 26548255 |
US |
2 | |
Product quality issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 349 | 26548257 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 350 | 26548258 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 351 | 26548300 |
US |
||
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 352 | 26548301 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 353 | 26548302 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 354 | 26548303 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 355 | 26548305 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 356 | 26548306 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 357 | 26548348 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 358 | 26548350 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 359 | 26548351 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 360 | 26548353 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 361 | 26548355 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 362 | 26548356 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 363 | 26548378 |
US |
2 | |
Product adhesion issue, No adverse event, |
||||
ESTRADIOL, |
||||
| 364 | 26548655 |
US |
||
No adverse event, |
||||
CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, |
||||
| 365 | 26552392 |
55 | 1 | |
No adverse event, |
||||
MAVACAMTEN, FUROSEMIDE, |
||||
| 366 | 26542006 |
US |
||
Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 367 | 26542122 |
US |
2 | |
Syringe issue, No adverse event, |
||||
FARICIMAB, FARICIMAB, FARICIMAB, FARICIMAB, |
||||
| 368 | 26542167 |
US |
||
Drug dose omission by device, Device delivery system issue, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 369 | 26542328 |
US |
||
No adverse event, Product dose omission issue, Product container issue, |
||||
| 370 | 26542340 |
US |
||
Intercepted product storage error, No adverse event, |
||||
OBINUTUZUMAB, |
||||
| 371 | 26542577 |
US |
||
Incorrect product administration duration, No adverse event, |
||||
ALTEPLASE, |
||||
| 372 | 26542588 |
US |
||
Wrong product administered, Product dispensing error, No adverse event, |
||||
DESVENLAFAXINE SUCCINATE, |
||||
| 373 | 26542616 |
US |
||
No adverse event, |
||||
BIMATOPROST, |
||||
| 374 | 26542783 |
US |
||
Product contamination physical, Poor quality product administered, No adverse event, |
||||
LIRAGLUTIDE, |
||||
| 375 | 26543055 |
US |
||
No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 376 | 26543063 |
US |
2 | |
Medication error, Product dose omission issue, No adverse event, Medication error, Medication error, Asthenia, Amnesia, Dyspnoea, Product quality issue, |
||||
ALBUTEROL SULFATE, |
||||
| 377 | 26543081 |
US |
34 | 2 |
Device malfunction, Product dose omission issue, No adverse event, Device malfunction, Product dose omission issue, No adverse event, |
||||
PEGFILGRASTIM-CBQV, PEGFILGRASTIM-CBQV, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PEGFILGRASTIM-CBQV, PEGFILGRASTIM-CBQV, |
||||
| 378 | 26543082 |
EU |
54 | 2 |
Suicide attempt, No adverse event, Intentional overdose, |
||||
PREGABALIN, |
||||
| 379 | 26543089 |
US |
||
Device malfunction, No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 380 | 26543096 |
US |
||
No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 381 | 26543321 |
US |
0 | |
Product storage error, No adverse event, |
||||
| 382 | 26543342 |
US |
2 | |
Product delivery mechanism issue, No adverse event, |
||||
AZELASTINE HYDROCHLORIDE, AZELASTINE, |
||||
| 383 | 26543348 |
US |
0 | |
Product storage error, No adverse event, |
||||
| 384 | 26543420 |
US |
||
Drug ineffective, No adverse event, |
||||
| 385 | 26543431 |
US |
2 | |
Drug ineffective, No adverse event, |
||||
| 386 | 26543436 |
US |
5 | |
Product dose omission issue, No adverse event, |
||||
BOSENTAN, |
||||
| 387 | 26543644 |
29 | ||
No adverse event, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 388 | 26543678 |
US |
2 | |
No adverse event, Device leakage, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 389 | 26543870 |
US |
33 | 1 |
Off label use, No adverse event, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, HYDROXYZINE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, LINEZOLID, DAPTOMYCIN, APIXABAN, APIXABAN, |
||||
| 390 | 26543951 |
US |
||
No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 391 | 26543967 |
US |
||
Device malfunction, No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 392 | 26544079 |
US |
||
No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 393 | 26544100 |
US |
||
Device malfunction, No adverse event, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 394 | 26544192 |
US |
2 | |
No adverse event, Environmental exposure, Device use error, Product label issue, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 395 | 26544246 |
US |
1 | 2 |
Product storage error, No adverse event, |
||||
| 396 | 26544274 |
US |
29 | 1 |
Contraindicated product administered, No adverse event, |
||||
| 397 | 26544346 |
US |
74 | 2 |
Product dose omission issue, Device defective, No adverse event, Device malfunction, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 398 | 26544368 |
US |
||
No adverse event, Product availability issue, Product dose omission issue, |
||||
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 399 | 26544426 |
US |
70 | 1 |
Product use in unapproved indication, No adverse event, |
||||
LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 400 | 26544522 |
US |
1 | |
Product delivery mechanism issue, No adverse event, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28